Usana Health Sciences (USNA) Gross Margin (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Gross Margin data on file, last reported at 76.25% in Q2 2026.

• Gross Margin for Q2 2026 came in at 76.25%, down 274.0% year-over-year; the trailing twelve-month figure through Apr 2026 was 77.55% (down 298.0% YoY), and the FY2026 annual result was 78.29%, down 284.0% from the prior year.
• Gross Margin fell to 76.25% in Q2 2026 per USNA's latest filing, from 78.16% in the prior quarter.
• Over five years, Gross Margin peaked at 81.95% in Q4 2024 and troughed at 76.25% in Q2 2026.
• A 5-year average of 80.02% and a median of 80.43% in 2023 frame the typical range for Gross Margin.
• The sharpest annual moves came in 2023 and 2026: Gross Margin jumped 123 bps in 2023, then plunged 379 bps in 2026.
• A 5-year view of Gross Margin shows it stood at 79.63% in 2022, then rose by 2 bps to 80.86% in 2023, then grew by 1 bps to 81.95% in 2024, then slipped by 6 bps to 77.15% in 2025, then retreated by 1 bps to 76.25% in 2026.
• Business Quant data shows USNA's Gross Margin at 76.25% in Q2 2026, 78.16% in Q1 2026, and 77.15% in Q3 2025.